CIK 0001645469
- Non-accelerated filer
- Smaller reporting company
Monopar Therapeutics
Sign in to watch- Ticker
- MNPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320463781
- Phone
- +1 847-388-0349
- Business address
- 1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
- 4 Open-market sale 10% owner sold 550,229 shares at $63.61 ($34,999,957)
- 4 Open-market sale Director sold 8,904 shares at $40.00 ($356,171)
- 4 Open-market sale Director sold 16,800 shares at $40.00 ($672,020)
- 4 Open-market sale Chief Executive Officer sold 16,800 shares at $40.00 ($672,020)
- 4 Shares withheld for taxes Chief Executive Officer gave up 5,865 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 2,990 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 33,334 shares at $35.00 ($1,166,690)
- 4 Shares withheld for taxes Chief Operating Officer gave up 744 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 1,204 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 1,759 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 3 of 13 · 247 filings